Transcription and splicing are functionally coupled, resulting in highly efficient splicing of RNA polymerase II (RNAP II) transcripts. The mechanism involved in this coupling is not known. To identify potential coupling factors, we carried out a comprehensive proteomic analysis of immunopurified human RNAP II, identifying >100 specifically associated proteins. Among these are the SR protein family of splicing factors and all of the components of U1 snRNP, but no other snRNPs or splicing factors. We show that SR proteins function in coupling transcription to splicing and provide evidence that the mechanism involves cotranscriptional recruitment of SR proteins to RNAP II transcripts. We propose that the exclusive association of U1 snRNP/SR proteins with RNAP II positions these splicing factors, which are known to function early in spliceosome assembly, close to the nascent pre-mRNA. Thus, these factors readily out-compete inhibitory hnRNP proteins, resulting in efficient spliceosome assembly on nascent RNAP II transcripts.
INTRODUCTION
In eukaryotes, pre-mRNA processing, which includes 5 0 capping, splicing, and polyadenylation, occurs cotranscriptionally (Bentley, 2005; Kornblihtt et al., 2004) . These processing steps are also functionally coupled to one another, meaning that one step affects the rate and/or efficiency of the other (Bentley, 2005; Buratowski, 2003; Kornblihtt et al., 2004; Maniatis and Reed, 2002; Manley, 2002; Proudfoot et al., 2002; Reed, 2003; Phatnani and Greenleaf, 2006; Adamson et al., 2005; Moteki and Price, 2002) . Functional coupling of transcription to RNA processing is mediated by the carboxy-terminal domain (CTD) of the largest subunit (Rpb1) of RNAP II (Phatnani and Greenleaf, 2006) . The CTD, which is composed of multiple heptapeptide repeats, serves as a binding platform for components of the RNA processing machineries that function in coupling (Phatnani and Greenleaf, 2006; Bentley, 2005; Buratowski, 2003; Meinhart et al., 2005) . Differential phosphorylation of the CTD repeats (consensus YSPTSPS) on serines 2 and 5 has numerous regulatory roles, determining the association/dissociation of transcription and RNA processing factors throughout the transcription cycle (Buratowski, 2003) .
A great deal of progress has been made in understanding coupling between transcription and splicing, revealing that transcription promotes splicing and, reciprocally, that splicing promotes transcription (Fong and Bentley, 2001; Ghosh and Garcia-Blanco, 2000; Das et al., 2006; Hicks et al., 2006; Fong and Zhou, 2001; Kwek et al., 2002) . The promoter type, the rate of elongation, transcriptional activators, and a chromatin remodeling factor have all been shown to affect alternative splicing in vivo (Batsche et al., 2006; de la Mata et al., 2003; Lacadie et al., 2006; Listerman et al., 2006; Nogues et al., 2003a Nogues et al., , 2003b . In addition, the observation that RNAP II transcripts are efficiently spliced in vivo when the intron is cleaved in the middle indicates the existence of a molecular tether between the nascent pre-mRNA and RNAP II (Dye et al., 2006) .
Numerous studies have also been carried out to identify splicing factors that interact with RNAP II, the CTD, or other components of the transcription machinery. Splicing factors or splicing-related proteins reported to interact with RNAP II include SCAFs, PSF/p54nrb, U2AF, SR proteins, and one or more of the five spliceosomal snRNPs (U1, U2, U4, U5, and U6) (Corden and Patturajan, 1997; Emili et al., 2002; Kameoka et al., 2004; Kim et al., 1997; Kwek et al., 2002; Morris and Greenleaf, 2000; Mortillaro et al., 1996; Patturajan et al., 1998; Robert et al., 2002; Yuryev et al., 1996; Ujvari and Luse, 2004) . Functional elongation complexes were also shown to contain, in addition to elongation factors (e.g., pTEFb and TAT-SF1), U1 snRNP alone or both U1 and U2 snRNPs (Kameoka et al., 2004) . More recently, however, it was reported that RNAP II immunopurified from mammalian cell extracts does not interact directly with any of the snRNPs in the absence of transcription (Listerman et al., 2006) . Thus, at present, no clear consensus has emerged regarding which splicing factors associate with RNAP II, and the functional significance of these associations in coupling transcription to splicing has also not been established.
Recently, efficient in vitro systems for coupling RNAP II transcription to splicing have been developed (Das et al., 2006; Hicks et al., 2006) , making it possible to carry out functional studies of coupling factors in vitro. Initial work with the coupled systems revealed that nascent pre-mRNA generated by RNAP II is rapidly and quantitatively packaged into the spliceosome, bypassing formation of the nonspecific hnRNP complex that forms on T7 RNA polymerase transcripts (Das et al., 2006) . Consequently, RNAP II transcripts are spliced more rapidly and efficiently than their T7 counterparts. Here, we show that SR proteins are required for coupling transcription to splicing and provide evidence that these early spliceosomal commitment factors are cotranscriptionally recruited to nascent RNAP II transcripts, thereby potently stimulating both spliceosome assembly and splicing.
RESULTS
To identify factors that might function in coupling transcription to splicing, we tested several well-characterized antibodies to Rpb1 to determine whether they could be used for immunopurification of RNAP II from HeLa nuclear extract. These antibodies included N20 (against the amino terminus), H14 (against serine 5 phosphoCTD), H5 (against serine 2 phoshoCTD), and 8WG16 (against both the unphosphorylated and phosphorylated CTD). The nuclear extract was incubated in the presence of ATP to turn over any potential endogenous spliceosomes assembled on pre-mRNAs in the extract (Konarska and Sharp, 1988) . Using optimized conditions for immunoprecipitation (see Experimental Procedures; Masuda et al., 2005) , only the 8WG16 antibody yielded a set of proteins that was readily detected on a Coomassie-stained gel and not in the negative control ( Figure 1A ). Western analysis of the 8WG16 immunoprecipitate using 8WG16, N20, or H14 antibodies revealed that the most abundant form of Rpb1 in the 8WG16 immunoprecipitate was phosphorylated, as expected in nuclear extract incubated in ATP ( Figure 1B , compare to nuclear extract [NE] that was not incubated in ATP).
We next analyzed the proteins present in the RNAP II immunoprecipitate by SDS-PAGE followed by mass spectrometry of individual bands ( Figure 1A) . Consistent with previous studies (Kameoka et al. [2004] , Yuryev et al. [1996] , Morris and Greenleaf [2000] , and references therein), we detected components of U1 snRNP, (E) Immunoprecipitation with RNAP II (8WG16) or control antibody from nuclear extract incubated in the presence (lanes 2 and 4) or absence (lanes 3 and 5) of ATP. One-seventh of the amount of nuclear extract used for the immunoprecipitation was used as a marker (lane 1). The 8% gel was stained with ethidium bromide. A longer exposure of the portion of the gel containing 7SK RNA is shown in the lower panel of (E).
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members of the SR protein family of splicing factors, and the transcription/splicing-related protein TLS/FUS ( Figure 1A , lane 2). We then carried out a comprehensive proteomic analysis of the RNAP II immunoprecipitate by mass spectrometry both of the entire gel lane (Table 1) and of a TCA precipitate of the RNAP II immunoprecipitate ( Table S1 in the Supplemental Data available with this article online). A set of $100 proteins was identified, which was largely the same with the two approaches (Table 1 and Table S1 ). Most importantly for the present study, every protein component of U1 snRNP (U170K, U1A, U1C, TIAR, TIA-1, and the Sm core proteins) was detected in the RNAP II immunoprecipitate. Despite the fact that snRNPs are abundant in the nuclear extract, the only other snRNP component detected by both approaches was U2-A 0 , a U2 snRNP protein shown in Drosophila to interact with U1 snRNP (Nagengast and Salz, 2001) . Our two mass spectrometry data sets further revealed that most of the SR protein family members, including SF2/ASF, 9G8, Tra2a and b, and SRPs 20, 40, 55, and 75 , are associated with RNAP II, whereas other splicing factors are not. When the nuclear extract was treated with RNase prior to 8WG16 immunoprecipitation, both U1 snRNP and SR proteins are not bound to RNAP II (data not shown). As U1 snRNP contains U1 snRNA, this RNase sensitivity is expected. In addition, U1 snRNP and SR proteins associate in a complex (Kohtz et al., 1994; see below) , and thus, SR proteins may interact with RNAP II in an RNase-sensitive manner via U1 snRNP. An alternative possibility is that the U1 snRNP/SR protein association with RNAP II is mediated by a nascent endogenous pre-mRNA in the nuclear extract. However, we feel that this is unlikely because U1 snRNP dissociates from the 5 0 splice site early in spliceosome assembly and has never been detected in spliceosomes in the absence of the other snRNPs (Fu, 1995) . Moreover, our functional data with SR proteins support the model that they are preassociated with RNAP II (see below).
Consistent with the mass spectrometry data, western analysis of the proteins that associate with RNAP II revealed high levels of the U1 snRNP components U1A and U170K ( Figure 1C ). In addition, SF2/ASF, TLS/FUS, and DSIF/SPT5 were detected ( Figure 1C ). Other abundant proteins were not detected, including U540K, U2AF, SAP 145, U2 B 00 , Aly, PSF, UAP56, and hTHO complex proteins ( Figure 1D and data not shown). Our mass spectrometry analysis detected hnRNP proteins in association with RNAP II (Table 1 and Table S1 ). However, western analysis revealed that, in contrast to U1A, U170K, and SF2/ASF, these hnRNP proteins, such as hnRNPs A and C, were not significantly enriched over the negative control immunoprecipitations or over nuclear extract ( Figure 1D ). These data indicate that U1 snRNP and SR proteins, but not hnRNP proteins, are specifically associated with RNAP II.
Consistent with the western and mass spectrometry data, high levels of U1 snRNA were detected in the 8WG16 immunoprecipitate, but not in side-by-side negative controls ( Figure 1E ). 7SK RNA, which negatively regulates the transcription elongation factor pTEF-B (Nguyen et al., 2001; Yang et al., 2001) , was also immunoprecipitated by the RNAP II antibody ( Figure 1E , longer exposure, lower panel). Both U1 snRNA and 7SK RNA associated with RNAP II in the presence or absence of ATP ( Figure 1E ). In contrast, the other spliceosomal snRNAs (U2, U4, U5, and U6) and 7SL RNA did not associate with RNAP II ( Figure 1E ). Together, our data indicate that U1 snRNP and SR proteins, both of which are known to be key factors in committing the pre-mRNA to the spliceosome assembly pathway, are unique among all splicing factors in their specific association with RNAP II. In our study, we did not detect several factors previously reported to associate with RNAP II, such as U2AF, PSF, p54nrb, or U2, U4, U5, and U6 snRNPs (see Introduction). This difference may be because other assays detect different populations of RNAP II.
RNAP II Associates with GST-SR Fusion Proteins
Several SR proteins coimmunoprecipitate with RNAP II ( Figure 1 , Table 1, and Table S1 ). To authenticate this association, we attempted reverse immunoprecipitations using antibodies to SR proteins. Western analysis of these immunoprecipitations revealed an RNAP II signal that was not significantly above background; RNAP II was also not significantly coimmunoprecipitated using antibodies to DSIF/SPT5, TLS/FUS, or U170K, suggesting that all of these factors may be inaccessible when bound to RNAP II (data not shown). As another approach for validating the association between SR proteins and RNAP II, we carried out a pull-down from nuclear extract using GST-SF2/ASF ( Figure 2 ). GST-UAP56, a protein component of the TREX complex (Masuda et al., 2005) , was used as a negative control ( Figure 2A ). As shown in Figure 2B , U1 snRNA associates with GST-SF2/ASF, but not with the negative control GST-UAP56. Moreover, western analysis of pull-downs from nuclear extract incubated in either the presence or absence of ATP showed that U170K and U1A were present in the GST-SF2/ASF, but not in the control pull-downs ( Figure 2C ). Previous studies had shown that U1 snRNP is specifically associated with SR proteins, consistent with our results (Kohtz et al., 1994) . The specificity of the GST pull-downs is further indicated by the observation that the TREX protein fSAP79 efficiently associated with GST-UAP56, but not with GST-SF2/ASF ( Figure 2C ).
To determine whether GST-SF2/ASF associates with RNAP II, western analysis of the +ATP and ÀATP pulldowns was carried out with N20, 8WG16, and H14 antibodies. Significantly, when the western blot was probed with N20 or 8WG16, both the dephosphorylated and phosphorylated forms of RNAP II were specifically detected in the GST-SF2/ASF pull-downs, but not in the negative control GST-UAP56 pull-downs ( Figure 2D ). The H14 antibody, which only detects the phosphorylated form of RNAP II, detected this form in the GST-SF2/ASF pull-down, but not in the negative control pull-down or in Figure 2D ). Consistent with the observation that SF2/ASF is associated with RNAP II, western analysis also revealed a specific association between the transcription elongation factor DSIF/Spt5 and GST-SF2/ASF in both the presence and absence of ATP ( Figure 2D ). The association of RNAP II with GST-SR proteins appears to be general, as we obtained the same results with GST-9G8 for pull-downs (data not shown). Together, our data show that an antibody to RNAP II specifically immunoprecipitates SR proteins (Figure 1) , and reciprocally, GST-SF2/ASF and GST-9G8 pull down RNAP II (Figure 2 and data not shown). We conclude that SR proteins specifically associate with RNAP II.
A Role for SR Proteins in Coupling Transcription to Splicing We next carried out functional studies to determine whether SR proteins are required for coupling transcription to splicing. Nuclear extract contains numerous SR protein family members, which often functionally substitute for one another (Fu, 1995) . Thus, we made use of two well-characterized RNA elements, known as FP and FPD, which are present in bovine growth hormone pre-mRNA. The FP RNA element (referred to here as SR RNA) is an exonic splicing enhancer that binds to multiple SR proteins, can bind synergistically to SF2/ASF and 9G8, and can titrate SR proteins in nuclear extract to potently inhibit splicing (Dirksen et al., 2000; Li et al., 2000; Sun et al., 1993) . The FPD RNA element (referred to here as cntl RNA) does not bind to SR proteins and does not inhibit splicing (Dirksen et al., 2000; Li et al., 2000; Sun et al., 1993) . As shown in Figure 3A , when nuclear extract was preincubated with 250 ng of either SR or cntl RNA, transcription of the CMV DoF DNA template was not affected (lanes 1 and 3), whereas splicing was blocked by SR RNA, but not by cntl RNA (lanes 2 and 4) . The same results were obtained with a CMV AdML DNA template (data not shown). We refer to the extracts preincubated with SR RNA and cntl RNA as DSR and Dcntl extracts, respectively. To verify that SR proteins complement the DSR extract for splicing, we used total SR proteins purified from HeLa cell nuclei (see Experimental Procedures). For the complementation assay, CMV DoF DNA was transcribed for 5 min in the DSR or Dcntl extract followed by addition of actinomycin D to block further transcription. Either buffer or SR proteins ( Figure 3B , lanes 1-8) were then added, and incubation was continued for a total of 60 min. As shown in Figure 3B , the SR proteins (lane 4), but not the buffer The 8WG16 antibody was used to immunopurify RNAP II and associated proteins from nuclear extract incubated in the presence of ATP. Mass spectrometry was carried out on total proteins fractionated by SDS-PAGE. The GenBank accession number for each protein is indicated. The number of total peptides (Total) and total unique peptides (Unique) identified for each protein is shown. Proteins are categorized according to their major functions. Proteins listed in the transcription/RNA-related category have known or proposed roles in both processes.
(lane 2), restored splicing to the DSR extract. As expected, no effect was observed in the Dcntl extract (lanes 5-8).
We conclude that the DSR extract is functionally depleted of SR proteins. The DSR and Dcntl extracts were then used in a series of experiments to determine whether SR proteins function in coupling transcription to splicing. In the first experiment, we added purified total SR proteins to the DSR extract either before or after carrying out transcription for 5 min (Figure 3C, lanes 4 and 7) . Actinomycin D was then added and incubation continued for 15 or 30 min (lanes 5, 6, 8, and 9). When the SR proteins were added before the 5 min transcription, efficient splicing occurred (lanes 4-6) . In contrast, the pre-mRNA was barely spliced at all when SR proteins were added after 5 min of transcription (lanes 7-9). Thus, in both cases, SR proteins were present early in the splicing reaction (within 5 min) but only functioned efficiently in splicing when they were present during transcription. These data, together with the observation that SR proteins associate with RNAP II (Figures 1 and 2) , indicate that SR proteins are cotranscriptionally recruited to nascent RNAP II transcripts, which strongly enhances splicing.
We next carried out a series of functional studies to verify the role of SR proteins in coupling transcription to splicing. As another approach for investigating whether the presence of SR proteins during versus after transcription affected splicing, the CMV DNA template was transcribed in the DSR extract for 5 min ( Figure 3D, lane 1) . An aliquot of this 5 min transcription reaction was then diluted 8-fold into a splicing reaction containing normal nuclear extract and actinomycin D, and incubated for 0, 30, or 60 min ( Figure 3D, lanes 3-5) . Significantly, even though this extract contained normal levels of SR proteins, the pre-mRNA remained unspliced by 30 and 60 min of incubation. In contrast, when transcription was carried out for 5 min in the Dcntl extract (i.e., in the presence of available SR proteins), the RNAP II transcript was efficiently spliced when an aliquot of the transcription reaction was diluted into the normal nuclear extract ( Figure 3D, lanes 8-10) . Thus, if the pre-mRNA is transcribed in the presence of available SR proteins, then it splices efficiently in normal nuclear extract. However, if the pre-mRNA is transcribed in the absence of available SR proteins, then it barely splices in normal nuclear extract. These data further support the conclusion that SR proteins function in coupling transcription to splicing (lanes 1 and 3) , actinomycin D was added, and incubation continued for 60 min (2 and 4). (B) DSR extract is complemented by SR proteins. Same as (A), except that 2 ml of buffer or 2 ml of total purified HeLa SR proteins ($10 mg) was added to the DSR or Dcntl extracts together with CMV DoF DNA. (C-E) SR proteins promote efficient splicing when available before, but not after, transcription. (C) CMV DoF DNA template was added to DSR nuclear extract, and then SR proteins were added before (lane 4) or after (lane 7) 5 min of transcription. Actinomycin D was added, and incubation continued for 15 or 30 min. In lanes 1-3, buffer was added instead of SR proteins before transcription. (D) Transcription in DSR or Dcntl extract followed by chasing in normal nuclear extract. CMV DoF was incubated in DSR or Dcntl extracts for 5 min (lanes 1 and 6) , actinomycin D was added, and incubation continued for 60 min (lanes 2 and 7) . An aliquot (3 ml) of the 5 min reaction from lanes 1 and 6 was diluted into a chase reaction (25 ml) containing normal nuclear extract and incubated for 0, 30, and 60 min (lanes 3-5 and 8-10). (E) CMV DoF was transcribed for 5 min (lanes 1 and 3) followed by addition of actinomycin D and 250 ng of SR RNA or cntl RNA. Incubation was continued for 60 min (lanes 2 and 4). (F) Excess SR RNA blocks splicing of T7 transcripts. Reactions in lanes 1, 2, 5, and 6 were carried exactly as in lanes 1, 2, 3, and 4, respectively, in (E). Lanes 3, 4, 7, and 8 were performed the same way except that T7 DoF DNA and T7 RNA polymerase were used in the reaction. The asterisk indicates a band of unknown origin that is detected with the T7 transcript, possibly a breakdown product of the pre-mRNA. via cotranscriptional recruitment of SR proteins to the nascent pre-mRNA.
To further substantiate this conclusion, we carried out transcription in normal nuclear extract for 5 min, added 250 ng of SR RNA and actinomycin D, and then continued the incubation for 60 min. Remarkably, the pre-mRNA synthesized for 5 min in normal nuclear extract was spliced with normal efficiency in the presence of the SR RNA even though this RNA was present at a $20,000fold molar excess over the level of the RNAP II transcript ( Figure 3E, lanes 1 and 2) . As shown above ( Figures 3A  and 3D, lanes 1 and 2) , this level of SR RNA completely blocks splicing when added prior to transcription. As expected, the cntl RNA did not affect splicing ( Figure 3E,  lanes 3 and 4) . Thus, when SR proteins are available during transcription, splicing is efficient in the presence of excess SR RNA. When SR proteins are unavailable prior to transcription, splicing is abolished. Together, the data indicate that SR proteins are stably and cotranscriptionally recruited to the nascent RNAP II transcript to promote efficient splicing.
Our data suggest that SR proteins are recruited more efficiently to pre-mRNA during transcription than to naked T7 transcripts. To test this possibility directly, we compared the splicing of naked T7 pre-mRNA to the corresponding RNAP II transcript generated in the coupled system after adding increasing amounts of SR RNA ( Figure S1 ). This analysis shows that splicing of the naked T7 transcript is significantly inhibited at the lowest level of SR RNA (25 ng) and completely blocked at the higher levels (75 and 125 ng). In contrast, splicing of the nascent RNAP II transcript is not affected at all at 25 ng and only partially affected at the higher levels ( Figure S1 ). We conclude that SR proteins are more efficiently recruited to nascent RNAP II transcripts than to naked T7 transcripts.
We next asked whether the potent effect of SR proteins on splicing nascent RNAP II transcripts is mediated by RNAP II or is simply transcription dependent. To do this, we carried out transcription in normal nuclear extract for 5 min with either RNAP II or T7 RNA polymerase and a T7-DNA construct ( Figure 3F) . A 20,000-fold excess of SR RNA or cntl RNA was then added, followed by actinomycin D, and continued incubation for 0 or 60 min. As shown in Figure 3F (lanes 1, 2, 5, and 6) , the CMV-DoF transcript was spliced with the same efficiency in the presence of both the SR and cntl RNAs, whereas T7-DoF splicing was abolished by the SR RNA but occurred in the presence of the cntl RNA ( Figure 3F, lanes 3, 4, 7, and  8) . These data indicate that the function of SR proteins in coupling transcription to splicing is RNAP II dependent.
To determine whether any early splicing factor would result in the same dramatic transcription-dependent effect on splicing that we see with SR proteins, we used oligonucleotide-directed RNase H cleavage to inactivate U2 snRNP and then used this inactivated extract for the same assay used for the SR proteins. As shown in Figure S2A , the cleavage of U2 snRNA is complete and specific, and no snRNAs are cleaved by the negative control oligonucleotide. Moreover, splicing is blocked in the U2 snRNP-inactivated extract, but not in the negative control extract ( Figure S2B ). Significantly, in sharp contrast to our results with SR proteins, we found no effect on splicing whether functional U2 snRNP was present before or after transcription, indicating that SR proteins, and not just any early splicing factor, have a transcriptiondependent requirement for efficient splicing (Figure S2C ).
Recombinant 9G8 Functions in Coupling Transcription to Splicing
We next purified individual recombinant SR proteins (SF2/ ASF and 9G8, Figure 4A ) and investigated whether they could function in coupling transcription to splicing. Our studies show that 9G8, but not SF2/ASF, complements T7-Ftz splicing in S100 extracts (data not shown). Consistent with this conclusion, addition of 9G8 to the DSR extract promotes splicing of CMV-Ftz in the coupled transcription/splicing system ( Figure 4B, lanes 1-4) . In contrast, SF2/ASF in combination with 9G8 (lanes 5 and 6) did not further enhance splicing, and SF2/ASF alone (lanes 7 and 8) did not promote splicing any better than the negative control protein (lanes 9 and 10). No effect on splicing was observed when any of the recombinant proteins were added to the Dcntl extract (lanes 11-16). We conclude that 9G8 rescues splicing of Ftz pre-mRNA in the DSR extract with the coupled transcription/splicing system. The rescue is less efficient than with total SR proteins ( Figure 3A) , possibly because other SR proteins are needed in conjunction with 9G8 and/or because recombinant proteins are less active than purified SR proteins.
To investigate whether 9G8 functions in coupling transcription to splicing, we added 9G8 either before or after 10 min of transcription in the DSR extract ( Figure 4C ). Consistent with our data using total SR proteins ( Figure 3C ), we observed splicing only when 9G8 was added before, but not after, transcription ( Figure 4C, lanes 1-6) . These data indicate that an individual purified SR protein (9G8) can function in coupling transcription to splicing.
GST-SR Proteins Are Dominant-Negative Inhibitors of Splicing When Added before, but Not after, RNAP II Transcription As an independent approach for investigating the role of SR proteins in coupling transcription to splicing, we purified GST-SF2/ASF, untagged SF2/ASF, or a negative control protein (GST-UAP56) ( Figure 5A ) and added them to untreated nuclear extract either before or after transcription, followed by splicing assays (Figures 5B-5E ). Splicing was inhibited when GST-SF2/ASF was added 10 min before transcription, but not when added after the 10 min transcription ( Figure 5B, lanes 1-4) . The negative control GST-UAP56 had no effect on splicing when added before or after transcription ( Figure 5B, lanes  5-8) . Moreover, the inhibitory effect of GST-SF2/ASF added prior to transcription was dose dependent ( Figure 5C ). In contrast to GST-SF2/ASF, recombinant SF2/ASF lacking the GST tag had no effect on splicing Figure 5D, lanes 5-12) . Thus, GST-SF2/ASF functions as a potent dominant-negative inhibitor of splicing, and this dominant-negative effect is not observed when endogenous SR proteins are available prior to transcription.
To determine whether other GST-SR proteins can function as dominant-negative splicing inhibitors, we added GST-9G8 to the coupled transcription/splicing system either before or after transcription ( Figure 5E ). Again, (lanes 1-2 and 11-12 ). The indicated proteins (350 ng each) were added to the DSR or Dcntl extracts. CMV DoF DNA was then added and incubated for 10 min followed by addition of actinomycin D and continued incubation for 40 more minutes. (C) CMV DoF DNA template was added to DSR nuclear extract and then 9G8 (350 ng) was added prior to (lanes 3 and 4) or after (lanes 5 and 6) 10 min of transcription. Actinomycin D was then added, and incubation continued for 40 more minutes. In lanes 1 and 2, buffer was added instead of 9G8 prior to transcription. Lanes 7 and 8 are the same as lanes 1 and 2 except Dcntl extract was used.
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splicing was blocked only when GST-9G8 was added prior to transcription. These data, together with the results in Figures 1-4 , provide evidence that SR proteins function in coupling transcription to splicing via cotranscriptional recruitment of the SR proteins to nascent RNAP II transcripts.
GST-SF2/ASF Is a Dominant-Negative Inhibitor of Spliceosome Assembly When Added before, but Not after, RNAP II Transcription To determine when during the splicing pathway GST-SR proteins inhibit splicing in the coupled transcription/splicing GST-SF2/ASF inhibits splicing when added to nuclear extract before, but not after, transcription. GST-SF2/ASF (1 mg) or GST-UAP56 (1 mg) was added to nuclear extract before or after 10 min of transcription of CMV DoF DNA template. Actinomycin D was added after the 10 min transcription and incubation continued for 30 additional minutes. (C) Dose-dependent inhibition of splicing by GST-SF2/ASF added prior to, but not after, transcription. Same as (A) except 1 (500 ng), 1.5 (750 ng), 2 (1 mg), or 2.5 (1.25 mg) ml of GST-SF2/ASF was added before or after transcription. (D) GST-SF2/ASF, but not SF2/ASF, inhibits splicing when added before, but not after, transcription. Same as (A) except GST-UAP56 (1 mg), SF2/ASF (lo = 500 ng, hi = 1 mg), or GST-SF2/ASF (1 mg) was added before or after transcription. (E) Same as (C) (lanes 13-16) , except GST-9G8 was used instead of GST-SF2/ASF. 
SR Proteins Couple Transcription to Splicing system, we added GST-SF2/ASF or GST-UAP56 to nuclear extract either before or after 10 min of transcription and then assayed for spliceosome assembly on a native agarose mini-gel ( Figure 6 ). Significantly, the spliceosome was assembled efficiently when GST-SF2/ASF was added after transcription ( Figure 6A, lane 3) or when GST-UAP56 was added before or after transcription ( Figure 6A, lanes 4  and 5) . In contrast, a small complex (*) was quantitatively assembled when GST-SF2/ASF was added to the extract before transcription ( Figure 6A, lane 2) . This complex appears to be nonfunctional, as it did not assemble into the spliceosome after continued incubation ( Figure 6B,  lanes 2 and 3) . We conclude that the dominant-negative effect of GST-SR proteins on splicing is exerted at the level of spliceosome assembly. This conclusion corroborates our observation that the coupling between transcription and splicing occurs via the immediate and quantitative assembly of the nascent RNAP II transcript into spliceosomes.
DISCUSSION
In this study, we investigated the mechanism for coupling RNAP II transcription to splicing by using a recently developed in vitro system for the coupling reaction (Das et al., 2006; Hicks et al., 2006) . In this system, splicing of RNAP II transcripts is dramatically enhanced relative to splicing of the corresponding T7 transcripts. This enhancement occurs because the nascent RNAP II transcripts are assembled into spliceosomes as rapidly as the transcripts are synthesized, bypassing assembly of the nonspecific H complex, which is largely composed of hnRNP proteins (Das et al., 2006) . To investigate the mechanism by which RNAP II promotes such rapid spliceosome assembly, we carried out a proteomic analysis of factors that associate with RNAP II immunopurified from nuclear extract. Significantly, we found that U1 snRNP and the SR protein family of splicing factors associate with RNAP II. Although the other spliceosomal snRNPs (U2, U4, U5, and U6) and splicing factors are present at high levels in the nuclear extract, these factors were not detected with RNAP II. Thus, the interaction of U1 snRNP/SR proteins with RNAP II is highly specific.
To determine whether SR proteins are indeed required for coupling transcription to splicing, we functionally depleted the nuclear extract of SR proteins and then tested whether the availability of SR proteins during transcription affected splicing efficiency. In all of the assays used, the data yielded the same result: splicing efficiency is strongly enhanced if SR proteins are available during transcription, but not if they are added immediately after transcription. No such effect is observed for another early splicing factor (U2 snRNP). The potent effect of SR proteins on splicing is observed with RNAP II, but not with T7 RNA polymerase, indicating that the effect is not simply due to transcription per se. As specific mutations in the CTD of the largest subunit of RNAP II impair cotranscriptional splicing in vivo (Bentley, 2005) , it is possible that SR proteins/U1 snRNP associate with the CTD.
Further evidence for a role of SR proteins in coupling transcription to splicing came from the observation that GST-SF2/ASF and GST-9G8 are dominant-negative inhibitors of splicing, but only if the GST-SR proteins are added prior to transcription. Furthermore, the GST-SR proteins completely block spliceosome assembly when added prior to, but not after, transcription. Together, our data are consistent with a model in which SR proteins and U1 snRNP are cotranscriptionally recruited to nascent RNAP II transcripts to promote spliceosome assembly, which in turn results in efficient splicing. This model remains to be directly verified by showing that U1 snRNP and SR proteins are transferred from an initially bound RNAP II onto the nascent pre-mRNA.
During the early steps in spliceosome assembly, SR proteins are recruited to exonic splicing enhancers and U1 snRNP to the 5 0 splice site (Hertel and Graveley, 2005; Fu, 2004; Nilsen, 2003) . These early steps are inhibited by the binding of hnRNP proteins to exonic splicing silencers (Han et al., 2005; Rothrock et al., 2005; Wang et al., 2004) . Based on these studies and our present work, we propose that the mechanism for coupling transcription to splicing involves tethering SR proteins/U1 snRNP directly to RNAP II so that these early factors have immediate access to the nascent transcript as it emerges from the exit pore of the polymerase ( Figure 7A ). In contrast, the inhibitory hnRNP proteins can only access the transcript by free diffusion and thus would be readily out-competed by the SR proteins/U1 snRNP. As a consequence, the pre-mRNA is efficiently directed into the spliceosome assembly pathway rather than into the inhibitory hnRNP complex. As most pre-mRNAs in higher eukaryotes contain multiple introns, it is possible that the elongating RNAP II is continuously ''recharged'' with SR proteins/U1 snRNP as these splicing factors are transferred onto the nascent transcript. In the absence of coupling between RNAP II transcription and splicing, hnRNP proteins and SR proteins/U1 snRNP compete for access to the T7 transcript ( Figure 7B ). The result is that a large portion of the T7 transcripts is assembled into the H complex and is subsequently degraded. A small portion of the naked pre-mRNA either directly assembles into the spliceosome or is first assembled into the H complex, which then assembles into the spliceosome.
Previous work showed that addition of SR proteins to nuclear extract commits pre-mRNA to spliceosome assembly (Fu, 1993) and increases the efficiency of spliceosome assembly/splicing of T7 transcripts (Fu, 1995) . However, this increase is nowhere near as great as is observed when SR proteins are present during transcription by RNAP II. Recent studies indicate that SR proteins play key roles in recognizing splicing signals and directly promoting snRNA-pre-mRNA interactions throughout spliceosome assembly Green, 2004, 2006) . Thus, the potent transcription-dependent effect of SR proteins on spliceosome assembly/splicing may be due to facilitation of these interactions.
Although it was recently shown that transcription and pre-mRNA splicing are functionally coupled in vitro (Das et al., 2006; Hicks et al., 2006; Ghosh and Garcia-Blanco, 2000) , the mechanism and factors involved in this coupling were not known. Our model that RNAP II associates with SR proteins/U1 snRNP, resulting in their efficient recruitment to the nascent transcript, fits well with the observation that the 5 0 splice site is the most conserved of the sequence elements involved in splicing. The combination of this conservation and the cotranscriptional recruitment of SR proteins/U1 snRNP would be expected to increase the fidelity of the earliest recognition of the exon/5 0 splice site in nascent pre-mRNAs.
EXPERIMENTAL PROCEDURES

Plasmids and Antibodies
PCR was used to construct transcription templates containing either the CMV or T7 promoter and encoding Ftz pre-mRNA (derivatives referred to as CMV-DoF and T7-DoF). SR and cntl RNAs are encoded on FP and FPD plasmids, respectively (Sun et al., 1993) . These plasmids were cut with BamH I and transcribed with T7 polymerase to generate RNAs that were 124 and 143 nt, respectively. The plasmid encoding GST-SF2/ASF was constructed by inserting a PCR product into the BamHI and EcoRI sites of pGEX2TK. The plasmid encoding GST-9G8 cDNA was constructed by inserting a PCR product into BamHI and SalI sites of pGex5X-3. GST proteins were expressed in E. coli. Antibodies 8WG16 and H14 (Covance), N20 (Santa Cruz), DSIF (BD bioscience), fSAP79 (Masuda et al., 2005) , U1 70K, U1 A, and U5 40K (generous gifts of R. Luhrmann), SF2/ASF (Hanamura et al., 1998) , TLS/Fus (generous gift of D. Goodman), hnRNP A1, and C (generous gifts of G. Dreyfuss) were used for westerns. Negative control antibodies were against hTho2 (Masuda et al., 2005) , B 00 (Mattaj et al., 1986) , or M3 (generous gift of M. Whitmann).
Coupled RNAP II Transcription and Splicing
In vitro transcription/splicing reactions were performed at 30 C in 25 ml reaction mixtures containing 200 ng DNA template, 1 ml 32 P-UTP (800 Ci/mmol), 15 ml HeLa nuclear extract (Krainer et al., 1984) , 0.5 mM ATP, 3.2 mM MgCl 2 , and 20 mM creatine phosphate (di-Tris salt). a-amanitin (0.4 mg/25 ml reaction) or actinomycin D (250 ng/25 ml reaction) was used to block transcription. Spliceosomes assembled in the coupled RNAP II transcription/splicing system were run on G-50 micro columns (Amersham Biosciences) to remove unincorporated 32 P-UTP. One microliter of heparin (6.5 mg/ml) was added to 10 ml of reaction prior to loading on 1.2% low melting point agarose gels (Das and Reed, 1999) .
Immunoprecipitations
To immunoprecipitate RNAP II, 8WG16 (Covance) or a negative control antibody was crosslinked to protein G Sepharose beads with dimethylpymelimidate (Sigma) at a 1:1 ratio of beads to antibody. Prior to immunoprecipitations, 1 ml reaction mixtures containing 300 ml nuclear extract were incubated under splicing conditions (30 C for 30 min) or in the absence of ATP (on ice for 30 min) and then spun for 5 min at 4 C in a microfuge. The supernatant was mixed with 500 ml buffer A (PBS/0.1% Triton X-100/0.2 mM PMSF), protease inhibitor EDTAfree (Roche), and 40 ml antibody-crosslinked beads. The mixtures were rotated overnight at 4 C. The beads were washed five times with buffer A. Total RNA was isolated from 5 ml of each immunoprecipitate, run on an 8% denaturing polyacrylamide gel, and stained with Figure 7 . Model for Cotranscriptional Recruitment of SR Proteins/U1 snRNP to Nascent RNAP II Transcripts (A) SR proteins/U1 snRNP associate with RNAP II. During transcription, these splicing factors are transferred from RNAP II to the exon/5 0 splice site. As a result, the spliceosome is efficiently assembled and splicing is efficient. (B) SR proteins/U1 snRNP compete with inhibitory hnRNP proteins for binding to naked T7 transcripts, resulting in a portion of the transcript binding these splicing factors and a portion binding inhibitory hnRNP proteins. The net result is that T7 transcripts assemble into both the spliceosome and the H complex, and the overall efficiency of spliceosome assembly and splicing is lower with the T7 versus RNAP II transcript. ethidium bromide. For analysis of proteins, 35 ml of the immunoprecipitate was mixed with protein gel loading buffer without DTT to elute the proteins at room temperature. DTT was added to the eluate to a final concentration of 40 mM, and a 5 ml aliquot of each sample was loaded on 4%-12% gradient gels (Invitrogen). For mass spectrometry of total proteins, the RNAP II and control immunoprecipitates were run 3 cm into an SDS gel, followed by Coomassie staining, and then each lane was cut into three regions. Total proteins in each region were identified by mass spectrometry. These data, presented in Table 1 , were verified by two independent control and RNAP II immunoprecipitations experiments. For Table S1 , RNAP II and control immunoprecipitates were precipitated with trichloroacetic acid, and the total mixture was used for mass spectrometry. Abundant nucleic acid binding proteins, such as ribosomal proteins, and/or proteins found in the negative control immunoprecipitate were not included in Table 1 . Proteins greater than 35 kDa for which only one peptide was identified and which were not identified by both mass spectrometry approaches were not included in Table 1 or Table S1 .
GST Pull-Downs GST pull-downs were carried out with nuclear extract reaction mixtures containing or lacking ATP. For the mixture containing ATP, 150 ml nuclear extract, 10 ml ATP (12.5 mM), 10 ml MgCl 2 (80 mM), 10 ml creatine phosphate (0.5 M), and 70 ml water were combined and incubated at 30 C for 10 min. The mixture was then spun at 4 C in a microfuge for 5 min, and the supernatant was used for pull-downs. For the mixture lacking ATP, the ATP was depleted by incubating the nuclear extract at room temperature for 10 min. One-hundred-fifty microliters of the ATP-depleted nuclear extract was then combined with 100 ml water and spun for 5 min. The supernatant was used for the pull-down. GST-SF2/ASF and GST-UAP56 were expressed in E. coli (BL21) and purified by binding to glutathione agarose (Amersham). After elution and dialysis, 10 mg GST fusion protein, 25 ml glutathione Sepharose 4B, 350 ml 1X PBS/0.1% Triton X-100/0.2 M PMSF/ protease inhibitor EDTA-free (Roche) was mixed with 250 ml nuclear extract mixture either containing or lacking ATP. Pull-downs were carried out at 4 C overnight and washed five times with 1X PBS/0.1% Triton X-100/0.2 M PMSF/protease inhibitor EDTA-free. To elute the proteins, 40 ml protein gel loading buffer without DTT was added to the beads and the samples were incubated for 10 min at room temperature. DTT was added to the eluate to a final concentration of 40 mM, and samples were fractionated by SDS-PAGE. For analysis of RNA in the pull-downs, total RNA was isolated from 15 ml of each pull-down, run on an 8% gel, and stained with ethidium bromide.
Functional Assays SR RNA is the well-characterized element from the bovine growth hormone exonic splicing enhancer (FP, 124 nt), and cntl is the control RNA (FPD, 143 nt) used in those studies (Sun et al., 1993; Li et al., 2000) . To prepare DSR and Dcntl extracts, 250 ng SR RNA or cntl RNA, respectively, was incubated in a 25 ml reaction mixture containing 15 ml nuclear extract, 0.5 mM ATP, 3.2 mM MgCl 2 , and 20 mM creatine phosphate for 20 min at 30 C. U2 snRNP-inactivated and control extracts were prepared by incubating 15 ml of nuclear extract with 450 ng of either U2 (5 0 -GGCCGAGAAGCGAT-3 0 ) or control (5 0 -GGGGTGAATTCTTTGCCAA-3 0 ) oligonucleotides at 30 C for 10 min. In Figure 4 , SF2/ASF and 9G8 were expressed in E. coli and mammalian cells, respectively. In Figures 5 and 6 , GST fusion proteins were expressed in E. coli.
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